Literature DB >> 20645867

Incidence of West Nile virus in birds arriving in wildlife rehabilitation centers in southern Spain.

Guillermo López1, Miguel Ángel Jiménez-Clavero, Ana Vázquez, Ramón Soriguer, Concha Gómez-Tejedor, Antonio Tenorio, Jordi Figuerola.   

Abstract

West Nile virus (WNV) is a neurotropic mosquito-transmitted flavivirus that in Eurasia, Africa, and the Americas primarily affects birds and secondarily other vertebrates. WNV has caused frequent massive episodes of wild bird mortality during its expansion throughout the Americas, and has become a regulating factor in the population dynamics of many wild bird species. On the other hand, WNV-related mortalities in wild birds have rarely been reported in the Mediterranean Basin despite its well-documented circulation, and only sporadic outbreaks in horses have been documented. The causes underlying this contrasting epidemiological pattern have never been properly described. An initial suggestion is that Mediterranean and American strains possess different pathogenicities, whereas an alternative view proposes that WNV-related disease and mortalities may have been overlooked in Europe. To test these hypotheses, between 2004 and 2006 in southern Spain we sampled tissue from 119 wild bird carcasses to detect WNV and other flaviviruses, as well as blood from 227 wild birds arriving in wildlife rehabilitation centers to test for WNV seroprevalence. No flavivirus was found in the tissue samples. The prevalence of WNV-neutralizing antibodies was 2.2%, similar to that of 800 healthy birds of the same species that were captured in the field. Our results suggest that WNV circulation during the study period did not result in any detectable effects in terms of bird morbidity or mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645867     DOI: 10.1089/vbz.2009.0232

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  6 in total

1.  High seroprevelance of West Nile virus antibodies observed in horses from southwestern Nigeria.

Authors:  Waidi Folorunso Sule; Daniel Oladimeji Oluwayelu; Rahamon Akinyele Moshood Adedokun; Nurudeen Rufai; Fiona McCracken; Karen L Mansfield; Nicholas Johnson
Journal:  Vector Borne Zoonotic Dis       Date:  2015-03       Impact factor: 2.133

2.  Serosurvey of West Nile virus (WNV) in free-ranging raptors from Brazil.

Authors:  Ana Paula Morel; Anelise Webster; Larissa Calo Zitelli; Karen Umeno; Ugo Araújo Souza; Fabiane Prusch; Marina Anicet; Gleide Marsicano; Paulo Bandarra; Gustavo Trainini; Julian Stocker; Denise Giani; Flávia Borges Fortes; Silvina Goenaga; José Reck
Journal:  Braz J Microbiol       Date:  2020-10-27       Impact factor: 2.476

3.  Extraordinary MHC class II B diversity in a non-passerine, wild bird: the Eurasian Coot Fulica atra (Aves: Rallidae).

Authors:  Miguel Alcaide; Joaquin Muñoz; Josué Martínez-de la Puente; Ramón Soriguer; Jordi Figuerola
Journal:  Ecol Evol       Date:  2014-02-13       Impact factor: 2.912

4.  Spatio-temporal trends and risk factors affecting West Nile virus and related flavivirus exposure in Spanish wild ruminants.

Authors:  Ignacio García-Bocanegra; Jorge Paniagua; Ana V Gutiérrez-Guzmán; Sylvie Lecollinet; Mariana Boadella; Antonio Arenas-Montes; David Cano-Terriza; Steeve Lowenski; Christian Gortázar; Ursula Höfle
Journal:  BMC Vet Res       Date:  2016-11-09       Impact factor: 2.741

Review 5.  Environmental drivers of West Nile fever epidemiology in Europe and Western Asia--a review.

Authors:  Shlomit Paz; Jan C Semenza
Journal:  Int J Environ Res Public Health       Date:  2013-08-09       Impact factor: 3.390

Review 6.  Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease.

Authors:  Cécile Beck; Miguel Angel Jimenez-Clavero; Agnès Leblond; Benoît Durand; Norbert Nowotny; Isabelle Leparc-Goffart; Stéphan Zientara; Elsa Jourdain; Sylvie Lecollinet
Journal:  Int J Environ Res Public Health       Date:  2013-11-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.